Diginex Clinches 98.8% Shareholder Approval for Resulticks, Yet Lender and Nasdaq Conditions Keep the Deal in Limbo

Diginex investors approved the Resulticks acquisition and share issuance, but lender consent and Nasdaq listing approval are still needed to close.

Diginex has cleared one of its most visible hurdles in the planned acquisition of Resulticks, but the approval that matters to the deal's completion still sits with parties other than its shareholders. A 5.0% gain in the stock on Friday does not, on its own, establish any direct link to the company's disclosure about the transaction.

What Shareholders Actually Approved

On Thursday, Diginex investors voted in favor of acquiring all outstanding Resulticks equity. The package put to them also covered the issuance of 600,000,000 new Diginex shares to fund the purchase price, a capital increase, and a 10:1 reverse stock split. The company reported the tally through a Form 6-K filing with the SEC on Friday: 98.809% of votes cast backed the proposal, a margin that leaves little doubt about shareholder sentiment.

That endorsement, however, should not be conflated with execution. Approval of a share issuance is not the same as the issuance itself, and a favorable acquisition vote is not a completed purchase. For investors weighing the transaction, the capital-structure changes tied to the deal belong in the same assessment as the acquisition itself.

The Price Tag Is Paid in Stock, Not Cash

The economics of the deal trace back to an agreement reached on August 14, under which Diginex will acquire 100% of Resulticks for US$1.05 billion. The entire consideration is to be settled in stock, with the 600,000,000 newly issued common shares earmarked for the sellers.

That structure matters. A share-based payment does not make an acquisition economically free — the sellers receive equity rather than cash, and existing holders must judge whether the value of what is being acquired justifies the dilution they will absorb. This is not an argument against the transaction as such. Stock consideration can align buyer and seller interests, but it shifts the critical test onto the worth of the target and the future participation in the combined earnings. The form of payment alone proves nothing about quality.

Financing Conditions Sit Outside the Ballot Box

Diginex disclosed supplementary details on Wednesday regarding Resulticks' Ascertis credit line. The total commitment stands at US$40.0 million, of which roughly US$31.8 million in principal remained outstanding. Additional facilities showed approximately US$21.0 million in outstanding principal.

The allocation of these obligations is the key point. Diginex stated it is not currently a party to the facility and has provided neither guarantees nor collateral for it. Resulticks' financing therefore should not be characterized as an existing Diginex credit obligation without that qualification. Diginex also noted it has not independently verified the information provided by Resulticks — a caveat that argues against treating the disclosure as a clean bill of health.

Even so, the financing remains central to the deal: completion requires, among other things, lender consent, alongside approval of the Nasdaq listing application. Shareholder approval and financing conditions are separate components of the same transaction, not substitutes for one another.

October 2026 Is a Target, Not a Guarantee

The stated target for closing is October 30, 2026. That date is an objective, not confirmation that the acquisition will be consummated on that day. The outstanding consents must continue to be treated as conditions rather than formalities.

The takeaway for investors is straightforward: the strong vote creates one prerequisite for the planned capital restructuring, but it does not replace the remaining approvals. What matters for valuation from here is actual transaction progress and the execution of the approved measures — not a single positive trading session. The deal will ultimately be measured against those standards.